13 results
Hypoglycemia Differential Diagnosis and Workup Algorithm
Firstly check if it is true (Whipple's triad).
After that, check labs
Hypoglycemia Differential ... Diagnosis and Workup ... #Differential # ... Diagnosis #Workup ... #Algorithm #endocrinology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
They work primarily ... a low risk of hypoglycemia ... upset (since it works ... #Pharmacology #Dosing ... Diabetes #DM2 #Endocrinology
Hypoglycemia Workup and Differential Diagnosis
Workup:
 • Sulfonylurea Labs
 • Anti-lnsulin Ab - Insulin Autoimmune Syndrome
 •
Hypoglycemia Workup ... and Differential ... Diagnosis Workup ... #Workup #Differential ... Diagnosis #insulinoma #endocrinology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Medications • SGLT2i ... Meglitinides • GLP ... #Medications #pharmacology ... pathophysiology #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... Contraindications: eGFR < 30 mL ... #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... Prandase) • SGLT ... INCRETIN AGENTS • GLP ... - Prevents GLP ... Diabetes #Management #pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... These work by inhibiting ... #Inhibitors #Pharmacology ... DM2 #Diabetes #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... Otherwise, it works ... when compared to SGLT2 ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Does not cause hypoglycemia ... initiate if eGFR < 45 mL ... #Metformin #Pharmacology ... DM2 #diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
DPP-4 inhibitor, GLP ... receptor agonist, SGLT2i ... #Medications #pharmacology ... comparison #table #endocrinology